Company Profile
Japan Tissue Engineering provides the regenerative medicine business in Japan. Its operations are structured into Regenerative Medicine Product, Regenerative Medicine Contract, and R&D Support segments.
It offers autologous cultured epidermis, cartilage, corneal epithelium, and oral mucosal epithelium to medical institutions for the purpose of medical treatment tissue-engineered medical products.
Additionally, it researches and develops human 3-dimensional cultured tissue models for use in the development of cosmetics and drugs for external use, as well as in research that employs skin and cornea tissues
Regenerative medicine contract development and manufacturing services. Founded in 1999, the company is headquartered in Gamagori, Japan. Japan Tissue Engineering Co., Ltd. operates as a subsidiary of Teijin Limited.